CrossPoint Therapeutics is developing next-generation ADCs and bispecific antibodies based on Stealth-Body, its proprietary Fc-inert antibody platform. By minimizing Fc-mediated off-target toxicity, we aim to improve therapeutic margin and expand the potential of antibody therapeutics for difficult-... Read more
Employees
1-10This company has no teams yet
This company has no offices yet